The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis

Journal of Interferon and Cytokine Research

Volumn 31, Issue 10, 2011, Pages 753-768

  Sosa, Rebecca A ^a   Forsthuber, Thomas G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; DENDRITIC CELL; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; MICROGLIA; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; AXONS; CELLULAR MICROENVIRONMENT; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; MULTIPLE SCLEROSIS; TH17 CELLS;

ANIMALIA;

EID: 80054715606     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0052     Document Type: Article

References (230)

1. Acarin L, Vela JM, Gonzalez B, Castellano B. 1994. Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat-brain by tomato lectin-binding. J Histochem Cytochem 42(8):1033-1041. (Pubitemid 24226330)
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappa B by toll-like receptor 3. Nature 413(6857):732-738. (Pubitemid 33009951)
3. Almolda B, González B, Castellano B. 2010. Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE. J Neuroimmunol 223(1-2):39-54.
4. Almolda B, Gonzalez B, Castellano B. 2011. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci 16:1157-1171.
5. Aloisi F, Ria F, Penna G, Adorini L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160:4671-4680. (Pubitemid 28215299)
6. Austyn JM, Gordon S. 1981. F4-80,a monoclonal-antibody directed specifically against the mouse macrophage. Eur J Immunol 11(10):805-815. (Pubitemid 12237981)
7. Bailey SL, Schreiner B, McMahon EJ, Miller SD. 2007. CNS myeloid DCs presenting endogenous myelin peptides 'pref-erentially' polarize CD4(+) T-H-17 cells in relapsing EAE. Nat Immunol 8(2):172-180. (Pubitemid 46152648)
8. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van-kooten C, Liu YJ, Rousset F, Saeland S. 1994. The CD40 antigen and its ligand. Ann Rev Immunol 12:881-922. (Pubitemid 24140434)
9. Barker AJ, Ullian EM. 2010. Astrocytes and synaptic plasticity. Neuroscientist 16(1):40-50.
10. Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW. 1992. AJR Am J Roentgenol 159:1041.
11. Becher B, Antel JP. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18(1):1-10. (Pubitemid 26369596)
12. Becher B, Blain M, Antel JP. 2000a. CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol 102(1):44-50.
13. Becher B, Dodelet V, Fedorowicz V, Antel JP. 1996. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 98(7):1539-1543. (Pubitemid 26327862)
14. Becher B, Durell BG, Noelle RJ. 2002. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Investig 110(4):493-497. (Pubitemid 34919703)
15. Becher B, Prat A, Antel JP. 2000b. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29: 293-304. (Pubitemid 30121420)
16. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4(2):121-132. (Pubitemid 43158155)
17. Biber K, Laurie DJ, Berthele A, Sommer B, Tolle TR, Gebicke-Harter PJ, van Calker D, Boddeke H. 1999. Expression and signaling of group I metabotropic glutamate receptors in as-trocytes and microglia. J Neurochem 72(4):1671-1680. (Pubitemid 29140843)
18. Binder GK, Griffin DE. 2001. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293(5528):303-306. (Pubitemid 32694747)
19. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S. 1994. Ann Neurol 36:778.
20. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. 2003. Mult Scler 9:323.
21. Brahic M, Roussarie JP. 2009. Axon-myelin interactions during a viral infection of the central nervous system. Plos Pathogens 5(9):e1000519.
22. Brockhaus J, Moller T, Kettenmann H. 1996. Phagocytozing ameboid microglial cells studied in a mouse corpus callosum slice preparation. Glia 16(1):81-90. (Pubitemid 26350514)
23. Brownell B, Hughes JT. 1962. J Neurol Neurosurg Psychiatry 25:315.
24. Bsibsi M, Persoon-Deen C, Verwer RWH, Meeuwsen S, Ravid R, Van Noort JM. 2006. Toll-like receptor 3 on adult human as-trocytes triggers production of neuroprotective mediators. Glia 53(7):688-695.
25. Bulloch K, Miller MM, Gal-Toth J, Milner TA, Gottfried-Blackmore A, Waters EM, Kaunzner UW, Liu K, Lindquist R, Nussenzweig MC, Steinman RM, McEwen BS. 2008. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol 508(5):687-710. (Pubitemid 351693557)
26. Bullock TH, Moore JK, Fields RD. 1984. Evolution of myelin sheaths-both lamprey and hagfish lack myelin. Neurosci Lett 48(2):145-148. (Pubitemid 14091910)
27. Burdeinick-Kerr R, Griffin DE. 2005. Gamma interferon-dependent, noncytolytic clearance of Sindbis virus infection from neurons in vitro. J Virol 79(9):5374-5385. (Pubitemid 40548206)
28. Carson MJ, Reilly CR, Sutcliffe JG, Lo D. 1998. Mature microglia resemble immature antigen presenting cells. Glia 22:72-85. (Pubitemid 28038045)
29. Carswell, R. 1838. Pathological Anatomy: Illustrations of the elementary forms of disease. Longman, Brown, Green and Longman, London, UK.
30. Cerwenka A, Carter LL, Reome JB, Swain SL, Dutton RW. 1998. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol 161(1):97-105. (Pubitemid 28285511)
31. Chakraborty S, Nazmi A, Dutta K, Basu A. 2010. Neurons under viral attack: Victims or warriors? Neurochem Int 56(6-7):727-735.
32. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000a. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20(17):6404-6412.
33. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Pre-myelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346(3):165-173. (Pubitemid 34438882)
34. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. 2000b. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta 2 subunit. Eur J Immunol 30(4):1113-1119. (Pubitemid 30216228)
35. Chang JY, Martin DP, Johnson EM. 1990. Interferon suppresses sympathetic neuronal cell-death caused by nerve growth-factor deprivation. J Neurochem 55(2):436-445.
36. Chang TT, Sobel RA, Wei T, Ransohoff RM, Kuchroo VK, Sharpe AH. 2003. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. Eur J Immunol 33(7):2022-2032. (Pubitemid 37120875)
37. Charcot JM. 1868. Histologie de la sclerose en plaques. Gazette Hôpitaux 41:554, 557-558.
38. Compston A, Coles A. 2008. Multiple sclerosis. Lancet 372(9648):1502-1517.
39. Constant SL, Bottomly K. 1997. Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches. Ann Rev Immunol 15:297-322. (Pubitemid 27169283)
40. Craggs RI, Webster HD. 1985. The examination of lesions in experimental allergic encephalomyelitis (EAE) for an antigen presenting cells (APCS). Neuropathol Appl Neurobiol 11(4):320-320.
41. Cua DJ. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744-748. (Pubitemid 36227625)
42. Czapiga M, Colton CA. 1999. Function of microglia in organo-typic slice cultures. J Neurosci Res 56(6):644-651. (Pubitemid 29246846)
43. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nature Neurosci 8(6):752-758. (Pubitemid 43085841)
44. Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kumpfel T, Moldenhauer A, Rader C, Sonderegger P, Pollmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, Karagogeos D, Hohlfeld R, Linington C, Meinl E. 2009. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci USA 106(20):8302-8307.
45. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392(6675):505-509. (Pubitemid 28168983)
46. Dijkstra IM, Hulshof S, van der Valk P, Boddeke H, Biber K. 2004. Cutting edge: Activity of human adult microglia in response to CC chemokine ligand 21. J Immunol 172(5):2744-2747. (Pubitemid 38263656)
47. Dorries R. 2001. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr Top Microbiol Immunol 253:219-245. (Pubitemid 32416667)
48. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315(5808):107-111. (Pubitemid 46196991)
49. ElKhoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. 1996. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382(6593):716-719. (Pubitemid 26282177)
50. Erichsen D, Lopez AL, Peng H, Niemann D, Williams C, Bauer M, Morgello S, Cotter RL, Ryan LA, Ghorpade A, Gendelman HE, Zheng JL. 2003. Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol 138(1-2):144-155. (Pubitemid 36566428)
51. Erkman L, Wuarin L, Cadelli D, Kato AC. 1989. Interferon induces astrocyte maturation causing an increase in cholinergic properties of cultured human spinal-cord cells. Dev Biol 132(2):375-388. (Pubitemid 19107507)
52. Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC. 2008. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci USA 105(40):15511-15516.
53. Fabry Z, Raine CS, Hart MN. 1994. Nervous-tissue as an immune compartment-the dialect of the immune-response in the CNS. Immunol Today 15(5):218-224. (Pubitemid 24137975)
54. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM. 1992. Different populations of macrophages use either the vitronectin receptor or the phos-phatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149(12):4029-4035. (Pubitemid 23068888)
55. Fan J, Bass HZ, Fahey JL. 1993. Elevated IFN-gamma and decreased IL-2 gene-expression are associated with HIV-infection. J Immunol 151(9):5031-5040.
56. Farber K, Pannasch U, Kettenmann H. 2005. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci 29(1):128-138. (Pubitemid 40613058)
57. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 159(1-2):12-19. (Pubitemid 40126172)
58. Ferber IA, Brocke S, TaylorEdwards C, Ridgway W, Dinisco C, Steinman L, Dalton D, Fathman CG. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalolmyelitis (EAE). J Immunol 156(1):5-7.
59. Fierz W, Endler B, Reske K, Wekerle H, Fontana A. 1985. As-trocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 134:3785-3793. (Pubitemid 15034390)
60. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. 1998. Ann Neurol 43:809.
61. Fischer HG, Reichmann G. 2001. Brain dendritic cells and mac-rophages/microglia in central nervous system inflammation. J Immunol 166: 2717-2726. (Pubitemid 32173513)
62. Flesch IEA, Kaufmann SHE. 1995. Differential induction of IL12 synthesis by Mycobacterium bovis BCG and Listeria mono-cytogenes. Res Immunol 146(7-8):520-525.
63. Fontana A, Fierz W, Wekerle H. 1984. Astrocytes present myelin basic-protein to encephalitogenic T-cell lines. Nature 307(5948): 273-276. (Pubitemid 14128971)
64. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154:4309-4321.
65. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. 1996. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617. (Pubitemid 26130658)
66. Fyffe-Maricich SL, Karlo JC, Landreth GE, Miller RH. 2011. The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation. J Neurosci 31(3): 843-850.
67. Gao X, Gillig TA, Ye P, D'Ercole AJ, Matsushima GK, Popko B. 2000. Interferon-gamma protects against cuprizone-induced demyelination. Mol Cell Neurosci 16(4):338-349.
68. Gehrmann J, Banati RB, Kreutzberg GW. 1993. Microglia in the immune surveillance of the brain-human microglia consti-tutively express HLA-DR molecules. J Neuroimmunol 48(2): 189-198. (Pubitemid 24010174)
69. Geiger K, Howes EL, Sarvetnick N. 1994. Ectopic expression of gamma-interferon in the eye protects transgenic mice from intraocular herpes-simplex virus type-1 infections. J Virol 68(9): 5556-5567. (Pubitemid 24258568)
70. Geissmann F, Jung S, Littman DR. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19(1):71-82. (Pubitemid 36859902)
71. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJA, Claassen E. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93(6):2499-2504. (Pubitemid 26104798)
72. Girvin AR, Dal Canto PC, Rhee L, Salomon B, Sharpe A, Blue-stone JA, Miller SD. 2000. A critical role for B7/CD28 costi-mulation in experimental autoimmune encephalomyelitis: A comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 164(1): 136-143. (Pubitemid 30012983)
73. Greenwald RJ, Latchman YE, Sharpe AH. 2002. Negative co-receptors on lymphocytes. Curr Opin Immunol 14(3):391-396. (Pubitemid 34327984)
74. Greter M. 2005. Dendritic cells permit immune invasion of the CNS during experimental autoimmune encephalomyelitis. Nat Med 11:328-334. (Pubitemid 40460562)
75. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11(3):328-334. (Pubitemid 40460562)
76. Griffin DE. 2003. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 3(6):493-502. (Pubitemid 37339189)
77. Hagino Y, Kariura Y, Manago Y, Amano T, Wang B, Sekiguchi M, Nishikawa K, Aoki SU, Wada K, Noda M. 2004. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 47(1):68-77. (Pubitemid 38879707)
78. Hauser SL, Oksenberg JR. 2006. The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 52(1):61-76. (Pubitemid 44466355)
79. Hausmann J, Pagenstecher A, Baur K, Richter K, Rziha HJ, Staeheli P. 2005. CD8 T cells require gamma interferon to clear Borna disease virus from the brain and prevent immune system-mediated neuronal damage. J Virol 79(21):13509-13518. (Pubitemid 41508163)
80. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D. 2006. The P2Y(12) receptor regulates microglial activation by extracellular nucleotides. Nature Neurosci 9(12): 1512-1519. (Pubitemid 44862659)
81. Heeger PS, Forsthuber T, Shive C, Biekert E, Genain C, Hofstetter HH, Karulin A, Lehmann PV. 2000. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J Immunol 164(11):5771-5781. (Pubitemid 30389820)
82. Hickey WF. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36(2):118-124. (Pubitemid 33055900)
83. Hickey WF, Kimura H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292. (Pubitemid 18061496)
84. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, Ahlfors H, Wilhelm C, Tolaini M, Menzel U, Garefalaki A, Potocnik AJ, Stockinger B. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12(3):255-U95.
85. Hochwald GM, Van DA, Robinson ME, Thorbecke GJ. 1988. Immune response in draining lymph nodes and spleen after intraventricular injection of antigen. Int J Neurosci 39:299-306.
86. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S. 2001. Extracellular ATP or ADP induce chemotaxis of cultured microglia through G(i/o)-coupled P2Y receptors. J Neurosci 21(6):1975-1982. (Pubitemid 32221381)
87. Howard LM. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest 103:281-290. (Pubitemid 29053146)
88. Hurwitz AA, Sullivan TJ, Krummel MF, Sobel RA, Allison JP. 1997. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol 73(1-2):57-62. (Pubitemid 27105269)
89. Inoue K. 2006. The function of microglia through purinergic receptors: Neuropathic pain and cytokine release. Pharmacol Ther 109(1-2):210-226. (Pubitemid 41740822)
90. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. 2006. Astrocytes promote myelination in response to electrical impulses. Neuron 49(6):823-832. (Pubitemid 43376080)
91. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S. 1998. Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol Brain Res 57(1):1-9. (Pubitemid 28279554)
92. Iyoda T, Shimoyama S, Liu K, Omatsu Y, Akiyama Y, Maeda Y, Takahara K, Steinman RM, Inaba K. 2002. The CD8(+) dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 195(10):1289-1302. (Pubitemid 34564331)
93. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175(7):4320-4330. (Pubitemid 41361966)
94. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 40(1): 55-72.
95. Janeway CA, Golstein P. 1992. lymphocyte-activation and effector functions-a return to intimacy. Curr Opin Immunol 4(3):241-245.
96. Jemison LM, Williams SK, Lublin FD, Knobler RL, Korngold R. 1993. Interferon-gamma-inducible endothelial-cell class-ii major histocompatibility complex expression correlates with strain-specific and site-specific susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol 47(1): 15-22. (Pubitemid 23274631)
97. Jonakait GM, Wei RT, Sheng ZL, Hart RP, Ni L. 1994. Interferon-gamma promotes cholinergic differentiation of embryonic septal nuclei and adjacent basal forebrain. Neuron 12(5):1149-1159.
98. Juedes AE, Ruddle NH. 2001. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166:5168-5175. (Pubitemid 32280732)
99. Kabat E, Wolf A, Bezer AE. 1947. The rapid production of acute disseminated encephalomyelitis in Rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J Exp Med 85:117-129.
100. Karandikar NJ, Vanderlugt CL, Bluestone JA, Miller SD. 1998. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. J Neuroimmunol 89:10-18. (Pubitemid 28389570)
101. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Blue-stone JA. 1996. CTLA-4: A negative regulator of autoimmune disease. J Exp Med 184(2):783-788. (Pubitemid 26324135)
102. Karlsen AE, Dyrberg T. 1998. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin Immunol 10(1):25-34. (Pubitemid 28108128)
103. Karman J, Ling C, Sandor M, Fabry Z. 2004. Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 173:2353-2361. (Pubitemid 39063091)
104. Katz-Levy Y. 2000. Temporal development of autoreactive Th1 responses and endogenous antigen presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Immunol 165:5304-5314.
105. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol 7(2):131-137. (Pubitemid 43135878)
106. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Ta-keuchi H, Suzumura A. 2008. Production and functions of IL-17 in microglia. J Neuroimmunol 194(1-2):54-61.
107. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WEF, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. 1999. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? J Exp Med 189(5):865-870. (Pubitemid 29189691)
108. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. 1999. Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17-26. (Pubitemid 29046269)
109. Kim YS, Choi DH, Block ML, Lorenzl S, Yang LC, Kim YJ, Su-gama S, Cho BP, Hwang O, Browne SE, Kim SY, Hong JS, Beal MF, Joh TH. 2007. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21(1):179-187. (Pubitemid 46052555)
110. Kim YS, Kim SS, Cho JJ, Choi DH, Hwang O, Shin DH, Chun HS, Beal MF, Joh TH. 2005. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J Neurosci 25(14):3701-3711.
111. Kishimoto H, Sprent J. 1999. Strong TCR ligation without cost-imulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4(+) T cells. J Immunol 163(4):1817-1826. (Pubitemid 29382180)
112. Kivisäkk P, Imitola J, Rasmussen S, Elyaman W, Zhu B, Ran-sohoff RM, Khoury SJ. 2009. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalo-myelitis. Ann Neurol 65(4):457-469.
113. Kivisakk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu LJ, Baekkevold ES, Lassmann H, Staugaitis SM, Campbell JJ, Ransohoff RM. 2003. Human cerebrospinal fluid central memory CD4(+) T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 100(14):8389-8394. (Pubitemid 36842555)
114. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K. 2007. UDP acting at P2Y(6) receptors is a mediator of microglial phagocytosis. Nature 446(7139):1091-1095. (Pubitemid 46676051)
115. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanoers MHJ. 1994. Annexin-V for flow cyto-metric detection of phosphatidylserine expression on B-cells undergoing apoptosis. Blood 84(5):1415-1420. (Pubitemid 24273007)
116. Kort JJ, Kawamura K, Fugger L, Weissert R, Forsthuber TG. 2006. Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J Neuroimmunol 173(1-2):23-34.
117. Krakowski ML, Owens T. 2000. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur J Immunol 30:1002-1009. (Pubitemid 30216215)
118. Kristensson K, Aldskogius M, Peng ZC, Olsson T, Aldskogius H, Bentivoglio M. 1994. Coinduction of neuronal interferon-gamma and nitric-oxide synthase in rat motor-neurons after axotomy-a role in nerve repair or death. J Neurocytol 23(8):453-459. (Pubitemid 24246611)
119. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749-1758. (Pubitemid 351957453)
120. Kulprathipanja NV, Kruse CA. 2004. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells. J Neu-roimmunol 153(1-2):76-82. (Pubitemid 38950929)
121. Kutzelnigg A, Lassmann H. 2005. Cortical lesions and brain atrophy in MS. J Neurol Sci 233(1-2):55-59. (Pubitemid 40804816)
122. Lande R, Gafa V, Serafini B, Giacomini E, Visconti A, Remoli ME, Severa M, Parmentier M, Ristori G, Salvetti M, Aloisi F, Coccia EM. 2008. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J Neuropathol Exp Neurol 67(5):388-401. (Pubitemid 351653532)
123. Lang HLE, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherp-fennig K, Stuart DI, Bell JI, Jones EY, Fugger L. 2002. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3(10):940-943. (Pubitemid 35154007)
124. Lanzavecchia A. 1997. Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 185(10):1717-1719.
125. Lau LT, Yu ACH. 2001. Astrocytes produce and release inter-leukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma 18(3):351-359. (Pubitemid 32230637)
126. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157.
127. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, Singh B, Thompson CB, Bluestone JA. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5(3):285-293. (Pubitemid 26341371)
128. Leonard JP, Waldburger KE, Goldman SJ. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin-12. J Exp Med 181(1):381-386.
129. Liblau RS, Singer SM, McDevitt HO. 1995. TH1 and TH2 CD4(+) T-cells in the pathogenesis of organ-specific autoimmune-diseases. Immunol Today 16(1):34-38.
130. Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C, Di Angelantonio S, Ragozzino D, Eusebi F. 2005. Chemokine CX(3)CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol 166(1-2): 19-28. (Pubitemid 41074653)
131. Lindsey JW, Steinman L. 1993. Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class-II messenger-RNA in the central-nervous-system during development and resolution of experimental allergic encephalomyelitis. J Neuroimmunol 48(2):227-234. (Pubitemid 24010179)
132. Ling C, Sandor M, Fabry Z. 2003. In situ processing and distribution of intracerebrally injected OVA in the CNS. J Neu-roimmunol 141:90-98. (Pubitemid 37289000)
133. Lumsden CE. 1970. Handbook of clinical neurology North-Holland, Amsterdam.
134. Ma XJ, Chow JM, Gri G, Carra G, Gerosa F, Wolf SE, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183(1):147-157. (Pubitemid 26028754)
135. Mack CL, Neville KL, Miller SD. 2003. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. J Neuroimmunol 144:68-79. (Pubitemid 37329931)
136. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Van-schie R, Laface DM, Green DR. 1995. Early redistribution of plasma-membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus-inhibition by overexpression of BCL-2 and ABL. J Exp Med 182(5):1545-1556.
137. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, Achim CL, McCutchan JA, Nelson JA, Atkinson JH, Grant I, Chandler JL, Wallace MR, Spector SA, Jernigan T, Hesselink J, Hansen L, Abramson I, Masys D, Group H. 1997. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 42(6):963-972. (Pubitemid 28008427)
138. Matsumoto Y, Fujiwara M. 1986. Insitu detection of class-i and class-ii major histocompatibility complex antigens in the rat central-nervous-system during experimental allergic enceph-alomyelitis-an immunohistochemical study. J Neuroimmu-nol 12(4):265-277. (Pubitemid 16013739)
139. Matsumoto Y, Ohmori K, Fujiwara M. 1992. Immune regulation by brain-cells in the central-nervous-system-microglia but not astrocytes present myelin basic-protein to encephalitogenic T-cells under invivo-mimicking conditions. Immunology 76(2): 209-216.
140. Matyszak MK, Perry VH. 1996. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74:599-608. (Pubitemid 26274227)
141. McCarron RM, Spatz M, Kempski O, McFarlin DE. 1986. Interactions between cerebral vascular endothelial-cells and myelin basic protein-sensitized T-cells. Can J Neurol Sci 13(4):370-370.
142. McCombe PA, Dejersey J, Pender MP. 1994. Inflammatory cells, microglia and mhc class-ii antigen-positive cells in the spinal-cord of lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 51(2):153-167. (Pubitemid 24147482)
143. McCombe PA, Fordyce BW, Dejersey J, Yoong G, Pender MP. 1992. Expression of cd45rc and ia-antigen in the spinal-cord in acute experimental allergic encephalomyelitis-an immuno-cytochemical and flow cytometric study. J Neurol Sci 113(2): 177-186. (Pubitemid 23000565)
144. McKenna K, Beignon AS, Bhardwaj N. 2005. Plasmacytoid dendritic cells: Linking innate and adaptive immunity. J Virol 79(1):17-27. (Pubitemid 39648359)
145. McMahon EJ. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11:335-339. (Pubitemid 40460563)
146. Miller DH, Barkhof F, Nauta JJ. 1993. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116(Pt 5):1077-1094. (Pubitemid 23329882)
147. Miller SD. 1995. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 3:739-745. (Pubitemid 26091147)
148. Miller SD. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-1136. (Pubitemid 27444456)
149. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. 1999. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5(1):49-55. (Pubitemid 29050998)
150. Monteyne P, Bureau JF, Brahic M. 1998. Viruses and multiple sclerosis. Curr Opin Neurol 11(4):287-291. (Pubitemid 28403099)
151. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. 2 Types of murine helper t-cell clone.1. definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348-2357. (Pubitemid 16136806)
152. Murphy Kea. 2008. Immunobiology. New York: Garland Science, Taylor & Francis Group.
153. Naik SH, Sathe P, Park HY, Metcalf D, Proietto AI, Dakic A, Carotta S, O'Keeffe M, Bahlo M, Papenfuss A, Kwak JY, Wu L, Shortman K. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 8(11): 1217-1226. (Pubitemid 350011760)
154. Nair A, Frederick TJ, Miller SD. 2008. Astrocytes in multiple sclerosis: A product of their environment. Cell Mol Life Sci 65(17):2702-2720.
155. Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468(7321):244-252.
156. Nikcevich KM, Gordon KB, Tan LJ, Hurst SD, Kroepfl JF, Gar-dinier M, Barrett TA, Miller SD. 1997. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 158(2):614-621. (Pubitemid 127492637)
157. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K. 2007. Involvement of P2X(4) and P2Y(12) receptors in ATP-induced microglial chemotaxis. Glia 55(6):604-616. (Pubitemid 46474302)
158. Oldstone MBA. 1987. Molecular mimicry and autoimmune-disease. Cell 50(6):819-820.
159. Oldstone MBA, VonHerrath M. 1996. Virus-induced autoimmune disease: Transgenic approach to mimic insulin-dependent diabetes mellitus and other autoimmune diseases. Apmis 104(10): 689-697. (Pubitemid 26400400)
160. Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG. 2007. Identification of clonogenic common Flt3(+) M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 8(11):1207-1216. (Pubitemid 350011759)
161. Oppmann B, Lesley R, Blom B, Timans JC, Xu YM, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu MR, Gorman D, Wagner J, Zurawski S, Liu YJ, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5):715-725.
162. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma JY, Dussault B, Woolf E, Alperin G, Culpep-per J, Gutierrez Ramos JC, Gearing D. 1997. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387(6633):611-617. (Pubitemid 27248766)
163. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple-sclerosis with gamma-interferon-exacerbations associated with activation of the immune-system. Neurology 37(7):1097-1102. (Pubitemid 17123439)
164. Park DR, Skerrett SJ. 1996. IL-10 enhances the growth of Le-gionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma-differential responses of blood monocytes and alveolar macrophages? J Immunol 157(6):2528-2538. (Pubitemid 126450466)
165. Patterson CE, Daley JK, Rall GF. 2002a. Neuronal survival strategies in the face of RNA viral infection. Journal of Infectious Diseases 186:S215-S219. (Pubitemid 35370484)
166. Patterson CE, Lawrence DMP, Echols LA, Rall GF. 2002b. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76(9):4497-4506. (Pubitemid 34309585)
167. Perrin PJ, Lovett-Racke A, Phillips SM, Racke MK. 1999. Differential requirements of naive and memory T cells for CD28 costimulationin autoimmune pathogenesis. Histol Histopathol 14(4):1269-1276. (Pubitemid 29447467)
168. Petersen MA, Dailey ME. 2004. Diverse microglial motility behaviors during clearance of dead cells in hippocampal slices. Glia 46(2):195-206. (Pubitemid 38596184)
169. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. 2001. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50(3):389-400. (Pubitemid 32848742)
170. Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A, Spano PF. 2004. Prevention of neuron and oligo-dendrocyte degeneration by interleukin-6 (IL-6) and IL-6 re-ceptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 25(2):301-311. (Pubitemid 38338641)
171. Pocock JM, Kettenmann H. 2007. Neurotransmitter receptors on microglia. Trends Neurosci 30(10):527-535. (Pubitemid 47513237)
172. Pohl HBF, Porcheri C, Mueggler T, Bachmann LC, Martino G, Riethmacher D, Franklin RJM, Rudin M, Suter U. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J Neurosci 31(3):1069-1080.
173. Ponomarev ED, Shriver LP, Maresz K, Dittell BN. 2005. Micro-glial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81(3):374-389. (Pubitemid 41359292)
174. Pope JG, Vanderlugt CL, Rahbe SM, Lipton HL, Miller SD. 1998. Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus. J Virol 72(10): 7762-7771. (Pubitemid 28421766)
175. Prat A, Biernacki K, Becher B, Antel JP. 2000. B7 expression and antigen presentation by human brain endothelial cells: Requirement for proinflammatory cytokines. J Neuropathol Exp Neurol 59(2):129-136. (Pubitemid 30106469)
176. Ransohoff RM, Kivisakk P, Kidd G. 2003. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3(7):569-581. (Pubitemid 37328676)
177. Richardson WD, Kessaris N, Pringle N. 2006. Oligodendrocyte wars. Nat Rev Neurosci 7(1):11-18. (Pubitemid 41828927)
178. Risau W, Engelhardt B, Wekerle H. 1990. Immune function of the blood-brain-barrier-incomplete presentation of protein (auto)antigens by rat-brain microvascular endothelium in-vitro. J Cell Biol 110(5):1757-1766. (Pubitemid 20169512)
179. Rivieccio MA, Suh HS, Zhao YM, Zhao ML, Chin KC, Lee SC, Brosnan CF. 2006. TLR3 ligation activates an antiviral response in human fetal astrocytes: A role for viperin/cig5. J Immunol 177(7):4735-4741. (Pubitemid 44469807)
180. Rockstroh JK, Kreuzer KA, Sauerbruch T, Spengler U. 1998. Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection. J Infect 37(3):282-286. (Pubitemid 29017276)
181. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, Nakane S, Papke LM. 2003. Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encepha-lomyelitis virus infection. J Virol 77(22):12252-12265. (Pubitemid 37339878)
182. Rottenberg M, Kristensson K. 2002. Effects of interferon-gamma on neuronal infections. Viral Immunol 15(2):247-260.
183. Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF. 2010. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. Plos One 5(10): e13693.
184. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Miller SD, Bluestone JA. 2001. Development of spontaneous autoimmune peripheral poly-neuropathy in B7-2-deficient NOD mice. J Exp Med 194(5): 677-684. (Pubitemid 32844777)
185. Sansom DM. 2000. CD28, CTLA-4 and their ligands: who does what and to whom? Immunology 101(2):169-177.
186. Santambrogio L, Belyanskaya SL, Fischer FR, Cipriani B, Bros-nan CF, Ricciardi-Castagnoli P, Stern LJ, Strominger JL, Riese R. 2001. Developmental plasticity of CNS microglia. Proc Natl Acad Sc USA 98(11):6295-6300. (Pubitemid 32488233)
187. Satoh J, Lee YB, Kim SU. 1995. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human mi-croglia but not in astrocytes in culture. Brain Res 704(1):92-96.
188. Savarin C, Bergmann CC, Hinton DR, Ransohoff RM, Stohlman SA. 2008. Memory CD4(+) T-cell-mediated protection from lethal coronavirus Encephalomyelitis. J Virol 82(24):12432-12440.
189. Sawada M, Suzumura A, Marunouchi T. 1995. Cytokine network in the central-nervous-system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13(3-4):253-264.
190. Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J. 1998. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121:2221-2228. (Pubitemid 28552461)
191. Scumpia PO, Kelly SM, Reeves WH, Stevens BR. 2005. Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52(2):153-162. (Pubitemid 41652919)
192. Seder RA, Paul WE. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T-cells. Ann Rev Immunol 12:635-673. (Pubitemid 24140427)
193. Segal BM, Dwyer BK, Shevach EM. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187(4):537-546. (Pubitemid 28093356)
194. Segal BM, Shevach EM. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 184(2):771-775. (Pubitemid 26324133)
195. Sellers DL, Maris DO, Horner PJ. 2009. Postinjury niches induce temporal shifts in progenitor fates to direct lesion repair after spinal cord injury. J Neurosci 29(20):6722-6733.
196. Serafini B, Columba-Cabezas S, Di RF, Aloisi F. 2000. In-tracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune enceph-alomyelitis. Am J Pathol 157:1991-2002.
197. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F. 2006. Dendritic cells in multiple sclerosis lesions: Maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 65(2): 124-141.
198. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2(3):151-161. (Pubitemid 37336516)
199. Shrestha B, Wang T, Samuel MA, Whitby K, Craft J, Fikrig E, Diamond MS. 2006. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 80(11):5338-5348.
200. Sobel RA, Blanchette BW, Colvin RB. 1984. Chronic experimental allergic encephalomyelitis (CEAE) follows anti-T-cell monoclonal-antibody modulation of acute EAE (AEAE) in adult guinea-pigs (GP). J Neuropathol Exp Neurol 43(3): 325-325.
201. Sonobe Y, Liang JF, Jin SJ, Zhang GQ, Takeuchi H, Mizuno T, Suzumura A. 2008. Microglia express a functional receptor for interleukin-23. Biochem Biophys Res Commun 370(1): 129-133.
202. Sospedra M, Martin R. 2005. Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747. (Pubitemid 40563183)
203. Stohwasser R, Giesebrecht J, Kraft R, Muller EC, Hausler KG, Kettenmann H, Hanisch UK, Kloetzel PM. 2000. Biochemical analysis of proteasomes from mouse microglia: Induction of immunoproteasomes by interferon-gamma and lipopolysac-charide. Glia 29(4):355-365. (Pubitemid 30121425)
204. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y. 2004. Production and release of neuroprotective tumor necrosis factor by P2X(7) receptor-activated microglia. J Neurosci 24(1):1-7. (Pubitemid 38181664)
205. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H. 2007. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. Plos Med 4(4):675-689. (Pubitemid 46658770)
206. Takiguchi M, Frelinger JA. 1986. Induction of antigen presentation ability in purified cultures of astroglia by interferon-gamma. J Mol Cell Immunol 2(5):269-280. (Pubitemid 16109383)
207. Talbot PJ, Paquette JS, Ciurli C, Antel JP, Ouellet F. 1996. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 39(2):233-240. (Pubitemid 26071574)
208. Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD. 1998. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J Immunol 160(9):4271-4279. (Pubitemid 28217282)
209. Taylor DL, Jones F, Kubota E, Pocock JM. 2005. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived fas ligand. J Neurosci 25(11): 2952-2964. (Pubitemid 40389253)
210. Thomas WE. 1992. Brain macrophages-evaluation of microglia and their functions. Brain Res Rev 17(1):61-74.
211. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161(7):3767-3775.
212. Traugott U, Lebon P. 1988. Interferon-gamma and ia-antigen are present on astrocytes in active chronic multiple-sclerosis lesions. J Neurol Sci 84(2-3):257-264. (Pubitemid 18087268)
213. Trembleau S, Germann T, Gately MK, Adorini L. 1995. The role of IL-12 in the induction of organ-specific autoimmune-diseases. Immunol Today 16(8):383-386.
214. Trotter J, Karram K, Nishiyama A. 2010. NG2 cells: properties, progeny and origin. Brain Res Rev 63(1-2):72-82.
215. Ulvestad E. 1994. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 56:732-740.
216. Utans-Schneitz U, Lorez H, Klinkert WEF, da Silva J, Lesslauer W. 1998. A novel rat CC chemokine, identified by targeted differential display, is upregulated in brain inflammation. J Neuroimmunol 92(1-2):179-190. (Pubitemid 29016003)
217. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M. 2002. Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligoden-droglial lineage cells. Mol Cell Neurosci 21(4):602-615. (Pubitemid 36062717)
218. Vanderlugt CJ, Miller SD. 1996. Epitope spreading. Curr Opin Immunol 8(6):831-836. (Pubitemid 27007649)
219. Vela JM, Molina-Holgado E, Arevalo-Martin A, Almazan G, Guaza C. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci 20(3):489-502. (Pubitemid 34971563)
220. Villadangos JA, Young L. 2008. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29(3):352-361.
221. Wang XH, Arcuino G, Takano T, Lin J, Peng WG, Wan PL, Li PJ, Xu QW, Liu QS, Goldman SA, Nedergaard M. 2004. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10(8):821-827. (Pubitemid 39070855)
222. Williams K, Ulvestad E, Antel JP. 1994a. B7/BB-1 antigen expression on adult human microglia studied in-vitro and in-situ. Eur J Immunol 24(12):3031-3037.
223. Williams KC, Dooley NP, Ulvestad E, Waage A, Blain M, Yong VW, Antel JP. 1995. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J Neurosci 15(3):1869-1878.
224. Williams KC, Ulvestad E, Hickey WF. 1994b. Immunology of multiple-sclerosis. Clin Neurosci 2(3-4):229-245.
225. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA. 1995. Expression of costimula-tory molecules B7-1 (CD80), B7-2 (CD86), and interleukin-12 cytokine in multiple-sclerosis lesions. J Exp Med 182(6): 1985-1996.
226. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18(2):601-609. (Pubitemid 28041896)
227. Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. 1984. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688-691. (Pubitemid 14054333)
228. Wu GF, Shindler KS, Allenspach EJ, Stephen TL, Thomas HL, Mikesell RJ, Cross AH, Laufer TM. 2011. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. J Autoimmun 36(1):56-64.
229. Wucherpfennig KW, Strominger JL. 1995. Molecular mimicry in t-cell-mediated autoimmunity-viral peptides activate human T-cell clones specific for myelin basic-protein. Cell 80(5): 695-705.
230. Yamada S, DePasquale M, Patlak CS, Cserr HF. 1991. Albumin outflow into deep cervical lymph from different regions of rabbit brain. Am J Physiol 261:H1197-H1204.